S2 Genomics Announces the NIC+ Cartridge for Isolating Nuclei from Sub-20 mg Tissue Samples

S2 Genomics, a manufacturer of automated tissue sample preparation systems, announced at the Advances in Genome Biology and Technology 2022 general meeting the launch of the NIC+ Small Sample Cartridge for nuclei isolations from solid tissue.

Poster Presented at AGBT 2022 General Meeting Demonstrates the NIC+ Improves the Efficiency and Reliability of Nuclei Isolations for Sub-20 mg Samples

LIVERMORE, Calif.--(BUSINESS WIRE)-- S2 Genomics, a manufacturer of automated tissue sample preparation systems, announced today at the Advances in Genome Biology and Technology (AGBT) 2022 general meeting the launch of the NIC+ Small Sample Cartridge for nuclei isolations from solid tissue. When used with the Singulator 100 TM System, the NIC+ cartridges automate the processing of solid tissue samples into suspensions of single nuclei with high yields and from sub-20 mg samples for a wide range of single-cell biology and genomic analyses.

Researchers are often faced with the challenge of isolating nuclei from scarce, precious samples. Samples less than 20 mg are often too small in size for efficient and reliable processing by manual methods. To ensure that researchers can isolate nuclei from sub-20 mg samples with consistency, the NIC+ cartridge (P/N 100-215-389) was developed for the Singulator 100 platform. A series of experiments were conducted to establish the performance of the NIC+ cartridges with respect to nuclei yield and quality.

“We’ve demonstrated that the NIC+ cartridge yields more, higher quality nuclei than the standard nuclei isolation cartridges,” said Dr. Stevan Jovanovich, President and CEO of S2 Genomics.

The NIC+ Small Volume cartridges will begin shipping in July 2022.

About S2 Genomics, Inc.

S2 Genomics, founded in 2016, is a leading developer of laboratory automation solutions for processing solid tissues for life science applications. S2 Genomics’ technology platforms integrate advanced fluidics, optics, and biochemistry to produce automated sample preparation solutions for the next generation sequencing (NGS) and cell biology markets, enabling discovery and innovation in life science research, healthcare, and agriculture. For more information, visit https://s2genomics.com.

For Research Use Only. Not for use in diagnostic procedures.

S2 Genomics, the S2 Genomics logo, and Singulator are trademarks of S2 Genomics, Inc.

Read the full press release here: https://s2genomics.com/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples

NIC+ Product information can be found here: https://s2genomics.com/small-sample-cartridge/

For the technical note visit: https://s2genomics.com/tech-note-use-of-nic-with-the-singulator-100-for-sub-20mg-samples To request a download of our AGBT 2022 posters or view the abstracts visit: https://info.s2genomics.com/en-us/agbt-2022-posters

View source version on businesswire.com: https://www.businesswire.com/news/home/20220606005233/en/

Contacts

Stevan Jovanovich
stevanj@s2genomics.com

Source: S2 Genomics, Inc.

Powered by Business Wire

View this news release online at:
http://www.businesswire.com/news/home/20220606005233/en

MORE ON THIS TOPIC